Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01396525 · ClinicalTrials.gov registry record · Phase 3
Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery
A Phase 3 study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- Phase 3
- Development phase
- 153
- Enrollment target
NCT01396525 is a Phase 3 study that has completed, run by Abbott Medical Devices. The registered enrollment target is 153 participants.
The verdict
NCT01396525, a Phase 3 study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 153 participants
- Enrollment target
Study Summary
To determine the safety and efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in subjects with atherosclerotic de novo or restenotic lesions in the native common iliac artery and/or native external iliac artery.
Interventions
- DEVICE Omnilink Elite™ Peripheral Balloon-Expandable Stent System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2009-03 |
| Est. Completion | 2014-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01396525
The ClinicalTrials.gov registry entry for NCT01396525 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omnilink Elite™ Peripheral Balloon-Expandable Stent System is the first listed.
NCT01396525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01396525 about?
NCT01396525 is a clinical study titled "Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery". To determine the safety and efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in subjects with atherosclerotic de novo or restenotic lesions in the native common iliac artery and/or native external iliac artery.
What is the current status of trial NCT01396525?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 153 participants. The study started on 2009-03. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01396525?
The interventions under investigation include: Omnilink Elite™ Peripheral Balloon-Expandable Stent System (DEVICE).
Who is sponsoring clinical trial NCT01396525?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.